Evidence map›Paper›PMID 33857731›Full record

Trial reportEarly human development2021

A pilot study to assess the safety, efficacy and ease of use of a novel hearing protection device for hospitalized neonates.

Michael J Balsan, Jeanne Burns, Fred Kimock, Emily Hirsch, Andrew Unger, Richard Telesco, Elisabeth Bloch-Salisbury

Registry-linked trialOpen access · greenAbstract readClinical Trial
In one paragraph

Trial report in Early human development, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03881553 (Interventions to Help Infants and Children Recover in the Hospital), which is not on this map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03881553 naterminatednot on this map

Interventions to Help Infants and Children Recover in the Hospital

TypeinterventionalSponsorElisabeth Salisbury, PhDRan2019 to 2020Enrolled17ConditionsInfant Apnea, Neonatal Abstinence Syndrome, SleepArmsNEATCAP, SVS mattress
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Michael J BalsanMagee-Womens, UPMC Hamot Hospital, Erie, PA, United States of America.
Jeanne BurnsMagee-Womens, UPMC Hamot Hospital, Erie, PA, United States of America.
Fred KimockNEATCap Medical, LLC, Bethlehem, PA, United States of America.
Emily HirschMagee-Womens, UPMC Hamot Hospital, Erie, PA, United States of America.
Andrew UngerNEATCap Medical, LLC, Bethlehem, PA, United States of America.
Richard TelescoMagee-Womens, UPMC Hamot Hospital, Erie, PA, United States of America.
Elisabeth Bloch-SalisburyUniversity of Massachusetts Medical School, Worcester, MA, United States of America. Electronic address: Salisburye2@upmc.edu.
UPMC Hamot · USUniversity of Massachusetts Chan Medical School · US

Funding

The Center for Advancing Point of Care in Heart, Lung, Blood and Sleep DiseasesU54HL143541 · NHLBI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI BRYAN O BUCHHOLZ, Nathaniel Scott Hafer · 2018 to 2026
$141.0M
University of Pittsburgh Clinical and Translational Science InstituteUL1TR001857 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2016 to 2025
$129.3M
NCATS NIH HHS UL1 TR001857NHLBI NIH HHS U54 HL143541
6 · The paper itself

Abstract

backgroundLoud noises in the neonatal intensive care unit (NICU) exacerbate patient cardiac and respiratory activity, disrupt sleep, and may contribute to hearing deficits, speech and language disorders, and neurodevelopmental delays among NICU graduates.

aimsThis study evaluated infant-patient tolerance and nurse ease of use of a novel frequency-selective hearing protection device, DREAMIES (NEATCap Medical, LLC). STUDY DESIGN AND SUBJECTS: Fifty neonates receiving care in a Level III NICU participated in a 2-phase prospective study. In Phase 1, 25 infants (mean 36.6 wks GA) wore DREAMIES for two consecutive 30-min periods. In Phase 2, 25 infants (mean 34.8 wks GA) wore DREAMIES between care and feeding times during an 8-h Device-On period followed by an 8-h Device-Off period for three consecutive days. OUTCOME MEASURES: Subject tolerance was defined by device-related skin irritation, vital sign measurements, and behavioral state. Device fit and ease of use were also evaluated by NICU nurses.

resultsNo skin breakdown was reported in any infant in either phase. Only transient skin erythema was observed. Periods when infants wore DREAMIES resulted in lower heart and respiratory rates and increased sleep (P < 0.001). Nurses reported little to no difficulty in applying or removing the device.

conclusionFindings suggest DREAMIES are a safe, easy to use, and effective device that reduces exposure to NICU noise, and may improve cardio-respiratory activity and promote sleep among neonatal patients. Further studies are warranted to examine longer term use and potential benefits of DREAMIES for improving outcomes in infants receiving NICU care. This trial is registered on clinicaltrials.govNCT02744066.

Indexed as

Hearing TestsIntensive Care Units, NeonatalHearingHumansInfantInfant, NewbornPilot ProjectsProspective StudiesInfant developmentalInfant sleepNICUNoise reductionNursingPremature infant

Identifiers

PMID33857731
PMCPMC8771502
OpenAlexW3151247576

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.